| Gene symbol | CTAG1B | Synonyms | CTAG, ESO1, CT6.1, CTAG1, LAGE-2, LAGE2B, NY-ESO-1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | cancer/testis antigen 1B | ||||
| GTO ID | GTC0249 |
| Trial ID | NCT02457650 |
| Disease | Melanoma | Breast Cancer | Neuroblastoma | Esophagus Sarcoma | Ovarian Cancer | Synovial Sarcoma | Multiple Myeloma | Bladder Carcinoma | Lung Cancer |
| Altered gene | NY-ESO-1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | NY-ESO-1 TCR-T cells |
| HLA | HLA-A2 |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | Phase I Study of Malignancies That Express NY-ESO-1 With T Cell Receptor-transduced T Cells Targeting NY-ESO-1 |
| Year | 2015 |
| Country | China |
| Company sponsor | Shenzhen Second People's Hospital |
| Other ID(s) | 201504002 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||||||||||
|
|||||||||||||||||||